How to assess treatment efficacy in Sjögren's syndrome?

A Vissink, H Bootsma, FGM Kroese… - Current opinion in …, 2012 - journals.lww.com
How to assess treatment efficacy in Sjögren's syndrome? : Current Opinion in Rheumatology
How to assess treatment efficacy in Sjögren's syndrome? : Current Opinion in Rheumatology …

Outcome measures for Sjögren's syndrome, April 10-11, 2003, Bethesda, Maryland, USA.

SR Pillemer, J Smith, PC Fox, SJ Bowman - The Journal of …, 2005 - jrheum.org
The goal of the Outcome Measures for Sjögren's Syndrome Workshop was to develop
consensus on a core set of outcome measures for clinical trials in Sjögren's syndrome (SS) …

New treatment guidelines for Sjögren's disease

FB Vivino, SE Carsons, G Foulks… - Rheumatic …, 2016 - rheumatic.theclinics.com
Among all the chronic autoimmune rheumatic disorders, Sjogren's disease (SD) is among
the most difficult to evaluate and manage. Clinicians are frequently challenged to …

Outcome measures for primary Sjögren's syndrome: a comprehensive review

R Seror, E Theander, H Bootsma, SJ Bowman… - Journal of …, 2014 - Elsevier
Lymphocytic infiltration of different exocrine and non-exocrine epithelia is the pathological
hallmark of primary Sjögren's syndrome, whereas involvement of salivary and lachrymal …

Expert perspective: challenges in Sjögren's disease

G Nocturne, X Mariette - Arthritis & Rheumatology, 2023 - Wiley Online Library
The management of Sjögren's disease is challenging because of several factors. Indeed, the
clinical presentations are heterogeneous, and one must be able to identify prognostic …

Guidelines for treatment of primary Sjögren's syndrome: a first useful stone but still much to do

R Seror, X Mariette - Rheumatology, 2017 - academic.oup.com
Guidelines can be defined as recommendations on the optimal way to manage and treat
patients with one condition. Establishing guidelines is a huge, difficult and timeconsuming …

Management of primary Sjögren's syndrome

LL Marshall, GA Stevens - The Consultant Pharmacist®, 2018 - ingentaconnect.com
Management of Primary Sjögren's Syndrome Page 1 Clinical Review Management of Primary
Sjögren’s Syndrome Leisa L. Marshall, Gregg A. Stevens OBJECTIVE: Review the clinical …

Why do drug treatments fail in Sjögren's disease? Considerations for treatment, trial design and interpretation of clinical efficacy

S Arends, GM Verstappen, L de Wolff… - Expert review of …, 2023 - Taylor & Francis
Introduction Despite ongoing efforts to develop effective therapeutics, no disease-modifying
drugs have been officially licensed for the indication of Sjögren's disease (SjD). This is partly …

EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies

M Ramos-Casals, P Brito-Zerón… - Annals of the …, 2020 - ard.bmj.com
The therapeutic management of Sjögren syndrome (SjS) has not changed substantially in
recent decades: treatment decisions remain challenging in clinical practice, without a …

Issues related to clinical trials of oral and biologic disease-modifying agents for Sjögren's syndrome

SE Carsons - Rheumatic Disease Clinics of North America, 2008 - Elsevier
Published studies and trials of oral and biologic disease-modifying antirheumatic drugs for
the treatment of Sjögren's syndrome have shown disappointing results. Improvements in trial …